Purification of DNA-origami nanostructures by rate-zonal centrifugation

Department of Cancer Biology, Dana-Farber Cancer Institute, Department of Biological Chemistry and Molecular Pharmacology and Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA.
Nucleic Acids Research (Impact Factor: 9.11). 11/2012; 41(2). DOI: 10.1093/nar/gks1070
Source: PubMed


Most previously reported methods for purifying DNA-origami nanostructures rely on agarose-gel electrophoresis (AGE) for separation. Although AGE is routinely used to yield 0.1-1 µg purified DNA nanostructures, obtaining >100 µg of purified DNA-origami structure through AGE is typically laborious because of the post-electrophoresis extraction, desalting and concentration steps. Here, we present a readily scalable purification approach utilizing rate-zonal centrifugation, which provides comparable separation resolution as AGE. The DNA nanostructures remain in aqueous solution throughout the purification process. Therefore, the desired products are easily recovered with consistently high yield (40-80%) and without contaminants such as residual agarose gel or DNA intercalating dyes. Seven distinct three-dimensional DNA-origami constructs were purified at the scale of 0.1-100 µg (final yield) per centrifuge tube, showing the versatility of this method. Given the commercially available equipment for gradient mixing and fraction collection, this method should be amenable to automation and further scale up for preparation of larger amounts (e.g. milligram quantities) of DNA nanostructures.


Available from: Minseok Kwak, Apr 17, 2014

Click to see the full-text of:

Article: Purification of DNA-origami nanostructures by rate-zonal centrifugation

6.02 MB

See full-text
  • [Show abstract] [Hide abstract]
    ABSTRACT: It is notoriously difficult to observe, let alone control, the position and orientation of molecules due to their small size and the constant thermal fluctuations that they experience in solution. Molecular self-assembly with DNA enables building custom-shaped nanometer-scale objects with molecular weights up to the megadalton regime. It provides a viable route for placing molecules and constraining their fluctuations in user-defined ways, thereby opening up completely new avenues for scientific and technological exploration. Here, we review progress that has been made in recent years toward the state of an enabled DNA nanotechnology.
    Current Opinion in Biotechnology 04/2013; 24(4). DOI:10.1016/j.copbio.2013.02.001 · 7.12 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: DNA nanotechnology, the design and self-assembly of artificial nucleic acid-based structures or systems, has developed with breathtaking pace in recent years. The technology offers an unparalleled ability to control structure and function at the molecular level and the sizes of the structures are expanding towards the micrometer domain. The question is whether the technology offers solutions to any real-life problems, or if it will remain an academic discipline. Here, we discuss this question by extrapolating from recent developments in the field.
    F1000 Prime Reports 05/2013; 5:14. DOI:10.12703/P5-14
  • [Show abstract] [Hide abstract]
    ABSTRACT: Many cytoskeletal motors function in groups to coordinate the spatial and temporal positioning of cellular cargo. While methods to study the biophysical properties of single motors are well established, methods to understand how multiple motors work synergistically or antagonistically are less well developed. Here, we describe a three-dimensional synthetic cargo structure made using DNA origami, which can be used to template defined numbers and types of cytoskeletal motors with programmable geometries and spacing. We describe methods for building the DNA origami structure, covalently attaching motors to DNA, forming the motor-DNA origami structure complex, and single-molecule assays to examine the motile properties of motor ensembles.
    Methods in enzymology 03/2014; 540:169-88. DOI:10.1016/B978-0-12-397924-7.00010-8 · 2.09 Impact Factor
Show more